Estados financieros detallados de Catalyst Pharmaceuticals, Inc. (CPRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Catalyst Pharmaceuticals, Inc. registró ingresos de $589.0M en el último ejercicio fiscal, con un CAGR de 5 años del 37.7%. El beneficio neto alcanzó $214.3M, con un CAGR a 5 años del 23.4%.
Márgenes de los últimos 12 meses: margen bruto 82.3%, margen operativo 44.8%, margen neto 37.1%. El flujo de caja libre creció a un CAGR del 35.9% en 5 años.
Al precio actual de $31.49, CPRX cotiza a un P/E de 17.49 y un ROE del 23.65%. La capitalización bursátil es de $3.9B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $500000 | $102.3M | $119.1M | $140.8M | $214.2M | $398.2M | $491.7M | $589.0M |
| Coste de Ventas | $43406 | $45689 | $19.9M | $14.8M | $17.0M | $21.9M | $34.4M | $52.0M | $68.8M | $87.3M |
| Beneficio Bruto | -$43406 | -$45689 | -$19.4M | $87.5M | $102.0M | $118.9M | $179.8M | $346.2M | $422.9M | $501.7M |
| I+D | $11.4M | $11.4M | $19.9M | $18.8M | $16.5M | $16.9M | $19.8M | $93.2M | $12.6M | $12.7M |
| Generales y Administrativos | $7.9M | $7.3M | $15.9M | $36.9M | $44.2M | $49.6M | $57.1M | $133.7M | $177.7M | $193.8M |
| Gastos Operativos | $19.3M | $18.7M | $35.8M | $55.7M | $60.7M | $66.6M | $78.0M | $259.4M | $227.8M | $244.0M |
| Beneficio Operativo | -$19.3M | -$18.7M | -$35.3M | $31.8M | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | $257.8M |
| EBITDA | -$18.0M | -$18.5M | -$35.3M | $31.9M | $41.4M | $52.9M | $106.0M | $127.4M | $254.0M | $321.4M |
| Gastos por Intereses | $321612 | $454163 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$18.1M | -$18.4M | -$34.0M | $33.4M | $41.9M | $52.7M | $104.7M | $94.5M | $216.3M | $283.5M |
| Impuestos | 0 | $141215 | 0 | $1.5M | -$33.1M | $13.2M | $21.6M | $23.1M | $52.4M | $69.2M |
| Beneficio Neto | -$18.1M | -$18.4M | -$34.0M | $31.9M | $75.0M | $39.5M | $83.1M | $71.4M | $163.9M | $214.3M |
| BPA | $-0.22 | $-0.21 | $-0.33 | $0.31 | $0.72 | $0.38 | $0.80 | $0.67 | $1.38 | $1.75 |
| BPA Diluido | $-0.22 | $-0.21 | $-0.33 | $0.30 | $0.71 | $0.37 | $0.75 | $0.63 | $1.31 | $1.68 |
| Acciones en Circulación (Diluidas) | $82.9M | $85.8M | $102.6M | $106.0M | $106.2M | $107.8M | $111.4M | $113.8M | $124.9M | $127.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Ingresos | $146.6M | $148.4M | $152.6M | $149.4M |
| Beneficio Bruto | $116.6M | $123.1M | $126.5M | $125.2M |
| Beneficio Operativo | $66.3M | $66.3M | $61.8M | $73.2M |
| EBITDA | $78.8M | $80.5M | $81.4M | $94.1M |
| Beneficio Neto | $52.1M | $52.8M | $52.7M | $63.7M |
| BPA | $0.43 | $0.43 | $0.42 | $0.52 |
| BPA Diluido | $0.41 | $0.42 | $0.40 | $0.50 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $13.9M | $57.5M | $16.6M | $89.5M | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | $709.2M |
| Inversiones a Corto | $26.5M | $26.5M | $36.9M | $5.0M | $10.0M | $19.8M | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $10.5M | $6.0M | $6.7M | $10.8M | $53.5M | $65.5M | $128.3M |
| Inventario | 0 | 0 | $56012 | $2.0M | $4.7M | $7.9M | $6.8M | $15.6M | $19.5M | $37.2M |
| Activos Corrientes | $41.5M | $85.2M | $55.2M | $111.4M | $159.2M | $210.1M | $320.8M | $219.3M | $623.6M | $894.0M |
| Inmovilizado Material | $244204 | $191385 | $245425 | $1.0M | $130000 | $4.0M | $3.6M | $3.7M | $3.6M | $3.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | $32.5M | $194.0M | $156.7M | $131.7M |
| Activos Totales | $41.7M | $85.4M | $60.4M | $112.4M | $192.4M | $237.8M | $375.6M | $470.1M | $851.4M | $1.11B |
| Cuentas por Pagar | $933176 | $1.9M | $2.3M | $4.1M | $4.3M | $2.8M | $4.0M | $14.8M | $16.6M | $11.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $437000 |
| Pasivos Corrientes | $2.1M | $4.3M | $9.5M | $24.1M | $22.8M | $27.1M | $57.6M | $76.1M | $120.7M | $147.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.4M | $4.4M | $9.7M | $24.7M | $22.8M | $31.0M | $75.2M | $82.2M | $123.8M | $152.5M |
| Reservas | -$108.1M | -$126.6M | -$160.6M | -$128.7M | -$53.7M | -$26.3M | $49.9M | $121.3M | $285.2M | $474.2M |
| Patrimonio Neto | $39.3M | $81.0M | $50.8M | $87.6M | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | $954.3M |
| Deuda Total | 0 | 0 | 0 | $948050 | $29000 | $4.2M | $3.9M | $3.6M | $3.2M | $2.8M |
| Deuda Neta | -$40.4M | -$84.0M | -$53.5M | -$93.6M | -$140.2M | -$187.1M | -$294.5M | -$134.1M | -$514.4M | -$706.4M |
| Capital Circulante | $39.4M | $80.9M | $45.7M | $87.3M | $136.5M | $183.0M | $263.2M | $143.3M | $502.9M | $746.9M |
Balance (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Caja y Equivalentes | $652.8M | $689.9M | $709.2M | $755.9M |
| Activos Totales | $971.9M | $1.05B | $1.11B | $1.15B |
| Pasivos Totales | $115.9M | $131.4M | $152.5M | $134.9M |
| Patrimonio Neto | $856.0M | $920.2M | $954.3M | $1.01B |
| Deuda Total | $3.0M | $2.9M | $2.8M | $2.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$18.1M | -$18.4M | -$34.0M | $31.9M | $75.0M | $39.5M | $83.1M | $71.4M | $163.9M | $214.3M |
| Amortizaciones | $43406 | $45689 | $37978 | $297726 | $885317 | $192000 | $1.2M | $32.9M | $37.8M | $37.9M |
| Compensación en Acciones | $1.8M | $2.4M | $3.6M | 0 | 0 | $6.1M | $7.9M | $14.2M | $22.3M | $24.8M |
| Cambio en Capital Circulante | -$884405 | $2.0M | $4.7M | -$1.1M | -$4.1M | $5.0M | $13.7M | -$37.3M | $30.9M | -$60.9M |
| Flujo de Caja Operativo | -$18.0M | -$13.7M | -$25.7M | $34.6M | $45.0M | $60.4M | $116.0M | $143.6M | $239.8M | $208.7M |
| Inversiones (CapEx) | -$96061 | 0 | -$92018 | -$19373 | -$11394 | -$1.0M | -$29000 | -$81.7M | -$556000 | -$58000 |
| Adquisiciones | $23465 | 0 | 0 | 0 | 0 | 0 | $10.0M | 0 | 0 | 0 |
| Recompra de Acciones | -$11265 | 0 | -$4448 | 0 | 0 | -$12.1M | -$6.9M | 0 | -$296000 | -$25.3M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$18.1M | -$13.7M | -$25.8M | $34.6M | $45.0M | $59.4M | $116.0M | $61.9M | $239.3M | $208.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Flujo de Caja Operativo | $71.3M | $32.4M | $44.9M | $59.6M |
| Inversiones (CapEx) | -$26000 | 0 | -$32000 | -$27000 |
| Flujo de Caja Libre | $71.3M | $32.4M | $44.9M | $59.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $7.6M | $5.7M | $5.7M | $6.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | +20361.2% | +16.4% | +18.3% | +52.1% | +85.9% | +23.5% | +19.8% |
| Crecimiento Beneficio Neto (anual) | | -1.9% | -84.7% | +193.7% | +135.2% | -47.3% | +110.4% | -14.0% | +129.5% | +30.8% |
| Crecimiento BPA (anual) | | +4.5% | -57.1% | +193.9% | +132.3% | -47.2% | +110.5% | -16.2% | +106.0% | +26.8% |
| Cambio en Acciones (anual) | | +3.5% | +19.6% | +3.3% | +0.2% | +1.5% | +3.3% | +2.1% | +9.8% | +1.9% |
| Crecimiento FCF (anual) | | +23.9% | -87.7% | +234.1% | +30.2% | +31.8% | +95.5% | -46.7% | +286.8% | -12.8% |
| Margen Bruto | | | -3883.8% | 85.6% | 85.7% | 84.5% | 83.9% | 86.9% | 86.0% | 85.2% |
| Margen Operativo | | | -7059.0% | 31.1% | 34.7% | 37.2% | 47.5% | 21.8% | 39.7% | 43.8% |
| Margen EBITDA | | | -7051.4% | 31.2% | 34.8% | 37.5% | 49.5% | 32.0% | 51.7% | 54.6% |
| Margen Neto | | | -6800.7% | 31.2% | 63.0% | 28.0% | 38.8% | 17.9% | 33.3% | 36.4% |
| Margen FCF | | | -5159.3% | 33.8% | 37.8% | 42.1% | 54.2% | 15.5% | 48.7% | 35.4% |
| Tasa Impositiva Efectiva | -0.0% | -0.8% | -0.0% | 4.6% | -79.0% | 25.0% | 20.7% | 24.4% | 24.2% | 24.4% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.22 | $-0.16 | $-0.25 | $0.33 | $0.42 | $0.55 | $1.04 | $0.54 | $1.91 | $1.64 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $82.9M | $85.8M | $102.6M | $102.9M | $103.5M | $103.4M | $103.4M | $106.3M | $118.5M | $122.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 23.65% |
| Rentabilidad sobre capital invertido | 19.67% |
| Rentabilidad sobre activos | 19.29% |
| Margen bruto | 82.32% |
| Margen operativo | 44.83% |
| Margen neto | 37.08% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.10 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 13.94 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -4.77 | -18.62 | -5.82 | 12.10 | 4.64 | 17.82 | 23.25 | 25.09 | 15.12 | 13.34 |
| P/VC | 2.21 | 4.14 | 3.88 | 4.41 | 2.04 | 3.38 | 6.40 | 4.61 | 3.40 | 2.99 |
| P/V | 0.00 | 0.00 | 394.11 | 3.77 | 2.90 | 4.97 | 8.98 | 4.49 | 5.03 | 4.85 |
| Margen Bruto | 0.0% | 0.0% | -3883.8% | 85.6% | 85.7% | 84.5% | 83.9% | 86.9% | 86.0% | 85.2% |
| Margen Operativo | 0.0% | 0.0% | -7059.0% | 31.1% | 34.7% | 37.2% | 47.5% | 21.8% | 39.7% | 43.8% |
| Margen Neto | 0.0% | 0.0% | -6800.7% | 31.2% | 63.0% | 28.0% | 38.8% | 17.9% | 33.3% | 36.4% |